Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

Journal of Clinical Investigation - Tập 105 Số 8 - Trang R15-R24 - 2000
Giannoula Klement1, Sylvain Baruchel, Janusz Rak, Shan Man, Katherine Clark, Daniel J. Hicklin, Peter Böhlen, Robert S. Kerbel
1Sunnybrook and Women's College Health Sciences Centre, Biological Sciences Program, Division of Cancer Biology Research, and Toronto-Sunnybrook Regional Cancer Centre, Toronto, Ontario M4N 3M5, Canada.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Folkman, 1972, Ann Surg, 175, 409, 10.1097/00000658-197203000-00014

Kerbel, 2000, Carcinogenesis, 21, 505, 10.1093/carcin/21.3.505

Ferrara, 1999, Nat Med, 5, 1359, 10.1038/70928

Presta, 1997, Cancer Res, 57, 4593

Witte, 1998, Cancer Metastasis Rev, 17, 155, 10.1023/A:1006094117427

Prewett, 1999, Cancer Res, 59, 5209

Fong, 1999, Cancer Res, 59, 99

Lin, 1997, J Clin Invest, 100, 2072, 10.1172/JCI119740

Boehm, 1997, Nature, 390, 404, 10.1038/37126

Kaban, 1999, Pediatrics, 103, 1145, 10.1542/peds.103.6.1145

Kerbel, 1991, BioEssays, 13, 31, 10.1002/bies.950130106

Gorski, 1999, Cancer Res, 59, 3374

Jain, 1998, Proc Natl Acad Sci USA, 95, 10820, 10.1073/pnas.95.18.10820

Benjamin, 1999, J Clin Invest, 103, 159, 10.1172/JCI5028

Denekamp, 1993, Br J Radiol, 66, 181, 10.1259/0007-1285-66-783-181

Tannock, 1970, Cancer Res, 30, 2470

Tannock, 1972, Cancer Res, 32, 77

Belotti, 1996, Clin Cancer Res, 2, 1843

O’Leary, 1999, Clin Cancer Res, 5, 181

Baguley, 1991, Eur J Cancer, 27, 482, 10.1016/0277-5379(91)90391-P

Schirner, 1998, Clin Cancer Res, 4, 1331

Presta, 1999, Cancer Res, 59, 2417

Yoshikawa, 1997, Kobe J Med Sci, 43, 109

Hirata, 1989, Arthritis Rheum, 32, 1065, 10.1002/anr.1780320903

Alon, 1995, Nat Med, 1, 1024, 10.1038/nm1095-1024

Yuan, 1996, Proc Natl Acad Sci USA, 93, 14765, 10.1073/pnas.93.25.14765

Stram, 1996, J Clin Oncol, 14, 2417, 10.1200/JCO.1996.14.9.2417

Rockwell, 1995, Mol Cell Different, 3, 91

Passaniti, 1992, Lab Invest, 67, 519

Bordow, 1994, Cancer Res, 54, 5036

Jain, 1990, Cancer Metastasis Rev, 9, 253, 10.1007/BF00046364

Teicher, 1992, Cancer Res, 52, 6702

Kakeji, 1997, Invest New Drugs, 15, 39, 10.1023/A:1005718628223

Tashiro, 1989, Cancer Chemother Pharmacol, 24, 187, 10.1007/BF00300241

Inaba, 1989, Cancer, 64, 1577, 10.1002/1097-0142(19891015)64:8<1577::AID-CNCR2820640803>3.0.CO;2-I

Gerber, 1998, J Biol Chem, 273, 30336, 10.1074/jbc.273.46.30336

Nor, 1999, Am J Pathol, 154, 375, 10.1016/S0002-9440(10)65284-4

Tran, 1999, Biochem Biophys Res Commun, 264, 781, 10.1006/bbrc.1999.1589

O’Connor, 2000, Am J Pathol, 156, 393, 10.1016/S0002-9440(10)64742-6

LaCasse, 1998, Oncogene, 17, 3247, 10.1038/sj.onc.1202569

Tamm, 1998, Cancer Res, 58, 5315

Mauceri, 1998, Nature, 394, 287, 10.1038/28412

Vacca, 1999, Blood, 94, 4143, 10.1182/blood.V94.12.4143

Clements, 1999, Cancer Chemother Pharmacol, 44, 411, 10.1007/s002800050997

Vartanian, 1995, Lab Invest, 73, 844

Asahara, 1999, EMBO J, 18, 3964, 10.1093/emboj/18.14.3964

Ito, 1999, Cancer Res, 59, 5875

Slaton, 1999, Clin Cancer Res, 5, 2726

Hainsworth, 1998, J Clin Oncol, 16, 2164, 10.1200/JCO.1998.16.6.2164

Rocca, 1999, Proc Am Soc Clin Oncol, 18, 121a

McLeod, 1999, Clin Cancer Res, 5, 2669

Lamont, 1999, Clin Cancer Res, 5, 2289